The Tokuhashi Score is a revised scoring system used to evaluate the prognosis of patients with metastatic spine tumors prior to surgery. It consists of 6 categories (A-F) that are each assigned a score of 0-2 or 0-5 based on factors like the patient's Karnofsky performance status, number of extraspinal bone metastases, primary cancer site, and neurological status. The total score predicts survival time: a score of 0-8 indicates survival less than 6 months; 9-11 indicates 6-12 months survival; and 12-15 indicates over 1 year survival.
The Tokuhashi Score is a revised scoring system used to evaluate the prognosis of patients with metastatic spine tumors prior to surgery. It consists of 6 categories (A-F) that are each assigned a score of 0-2 or 0-5 based on factors like the patient's Karnofsky performance status, number of extraspinal bone metastases, primary cancer site, and neurological status. The total score predicts survival time: a score of 0-8 indicates survival less than 6 months; 9-11 indicates 6-12 months survival; and 12-15 indicates over 1 year survival.
The Tokuhashi Score is a revised scoring system used to evaluate the prognosis of patients with metastatic spine tumors prior to surgery. It consists of 6 categories (A-F) that are each assigned a score of 0-2 or 0-5 based on factors like the patient's Karnofsky performance status, number of extraspinal bone metastases, primary cancer site, and neurological status. The total score predicts survival time: a score of 0-8 indicates survival less than 6 months; 9-11 indicates 6-12 months survival; and 12-15 indicates over 1 year survival.
The Tokuhashi Score is a revised scoring system used to evaluate the prognosis of patients with metastatic spine tumors prior to surgery. It consists of 6 categories (A-F) that are each assigned a score of 0-2 or 0-5 based on factors like the patient's Karnofsky performance status, number of extraspinal bone metastases, primary cancer site, and neurological status. The total score predicts survival time: a score of 0-8 indicates survival less than 6 months; 9-11 indicates 6-12 months survival; and 12-15 indicates over 1 year survival.
0 Poor (10%-40%) A 1 Karnofsky Index Moderate (50%-70%) 2 Good (80%-100%) 0 ≥3 Number of B 1 extraspinal bone 1-2 metastases foci 2 0 0 Number of ≥3 metastases in C 1 2 the vertebral 2 body 1 0 Unremovable Metastases to D 1 major internal Removable organs 2 No metastases 0 Lung, osteosarcoma, stomach, bladder, esophagus, pancreas 1 Liver, gallbladder, unidentified 2 Primary cancer Others E 3 site Kidney, uterus 4 Rectum 5 Thyroid, prostate, breast carcinoid tumor Complete (Frankel A, B)
A: Lesion is found to be complete both motor and sensory below
0 the segmental level marked.
B: Some sensation present below the level of the lesion but that the motor paralysis is complete below that level.
Incomplete (Frankel C, D) F Palsy5 C: Some motor power present below the lesion but it is of no 1 practical use to the patient.
D: Useful motor power below the level of the lesion. Patients in
this group could move the lower limbs and any could walk, with or without aids. None (Frankel E) 2 E: Patient is free of neurological symptoms, i.e. no weakness, no sensory loss, no sphincter disturbance. Abnormal reflexes may have been present.
Total Score A-F = 0-8; Survival <6 month
Total Score A-F = 9-11; Survival 6-12 month Total Score A-F = 12-15; Survival >1 year
4. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30:2186-91. 5. Frankel HL, Hancock DO, Hyslop G, et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 1969;7:179-92.
